Aetiology and outcome of acute hepatic failure in Greece: Experience of two academic hospital centres

Liver International

Volumn 28, Issue 6, 2008, Pages 821-827

  Koskinas, John ^a   Deutsch, Melanie ^a   Kountouras, Dimitris ^a   Kostopanagiotou, Georgia ^b   Arkadopoulos, Nikos ^b   Smyrniotis, Vasilis ^b   Rapti, Irene ^a   Manesis, Emmanuel ^a   Archimandritis, Athanasios ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Acute liver failure; Epidemiology; Greece; Outcome

Indexed keywords

BILIRUBIN; CYPROTERONE ACETATE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GREECE; HEPATITIS B; HEPATITIS B VIRUS; HOSPITAL; HUMAN; LIVER FAILURE; LIVER TOXICITY; LIVER TRANSPLANTATION; MALE; OVERALL SURVIVAL; PROGNOSIS; RISK FACTOR; SURVIVAL RATE;

EID: 44949141520     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01782.x     Document Type: Article

References (20)

1. Lee WM. Medical progress: Acute liver failure. N Engl J Med 1993; 329: 1862-72.
2. Bower WA, Johns M, Margolis HS, Williams IT, Bell BP. Population-based surveillance for acute liver failure. Am J Gastroenterol 2007; 102: 2459-63.
3. Bernal W. Changing patterns of causation and the use of transplantation in the United Kingdom. Semin Liver Dis 2003; 23: 227-37.
4. Acharya SK, Panda SK, Saxena A, Gupta SD. Acute hepatic failure in India: A perspective from the East. J Gastroenterol Hepatol 2000; 15: 473-9.
5. Acharya SK, Dasarathy S, Kumer TL, et al. Fulminant hepatitis in a tropical population: Clinical course, cause, and early predictors of outcome. Hepatology 1996; 23: 1445-55.
6. Bismuth H, Samuel D, Castaing D, et al. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg 1995; 222: 109-19.
7. Schiodt FV, Atillasoy E, Shakil AO, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg 1999; 5: 29-34.
8. Lau GK. Hepatitis B infection in China. Clin Liver Dis 2001; 5: 361-79.
9. Papaevangelou G, Tassopoulos N, Roumeliotou-Karayannis A, Richardson C. Etiology of fulminant viral hepatitis in Greece. Hepatology 1984; 4: 369-72.
10. O'Grady JG, Schalm SW, William R. Acute liver failure: Redefining the syndromes. Lancet 1993; 342: 273-5.
11. Stravitz RT, Kramer AH, Davern T, et al. Intensive care of patients with acute liver failure: Recommendations of the US Acute Liver Failure Study Group. Crit Care Med 2007; 35: 1-11.
12. Zaman MB, Hoti E, Qasim A, et al. MELD score as a prognostic model for listing acute liver failure patients for liver transplantation. Transpl Proc 2006; 38: 2097-8.
13. Katoonizadeh A, Decaestecker J, Wilmer A, et al. MELD score to predict outcome in adult patients with non-acetaminophen-induced acute liver failure. Liver Int 2007; 27: 329-34.
14. Ostapowicz G, Fontana R, The US Acute Liver Failure Study Group, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 202: 947-54.
15. Ellis A, Rhodes A, Jackson N, et al. Acute liver failure (ALF) in a specialist intensive care unit; a 7 year experience. Crit Care 1998; 2: P150.
16. Williams R. Classification, etiology, and considerations of outcome in acute liver failure. Semin Liver Dis 1996; 16: 343-8.
17. Larsen FS, Kirkegaard P, Rasmussen A, Hansen BA. The Danish liver transplantation program and patients with serious acetaminophen intoxication. Transpl Proc 1995; 27: 3519-20.
18. Stedman C. Herbal hepatotoxicity. Semin Liver Dis 2002; 22: 195-206.
19. Wright TL, Mamish D, Combs C, et al. Hepatitis B virus and apparent fulminant non-A, non-B hepatitis. Lancet 1992; 339: 952-5.
20. Pelaez-Luna M, Martinez-Salgado J, Olivera-Martinez MA. Utility of the MAYO end-stage liver disease score, King's college criteria, and a new in-hospital mortality score in the prognosis of in-hospital mortality in acute liver failure. Transpl Proc 2006; 38: 927-9.